Compositions and methods for activating “stimulator of interferon gene”-dependent signalling
US-10906930-B2 · Feb 2, 2021 · US
This page is not indexed by search engines while we improve data quality.
Kanne David patents
Kanne David is listed as an inventor on 4 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Kanne David |
| Total patents | 4 |
| First publication | Oct 6, 2016 |
| Latest publication | Feb 2, 2021 |
Notable patents
Publications ranked by popularity score, then publication date.
Compositions and methods for activating "stimulator of interferon gene"-dependent signalling
US-2019062365-A1 · Feb 28, 2019 · US
Use of sting agonist as cancer treatment
US-2018028553-A1 · Feb 1, 2018 · US
Use of sting agonist as cancer treatment
US-2016287623-A1 · Oct 6, 2016 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Aduro Biotech Inc | 4 |
| Univ Chicago | 2 |
| Novartis Ag | 2 |
| Chinook Therapeutics Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 4 |
| A61K45/06 | 4 |
| A61P35/02 | 2 |
| A61K31/7084 | 2 |
| A61P43/00 | 2 |